What drove the after-hours move in 4LL.F stock on 23 Feb 2026?

The move followed positioning ahead of Teladoc’s earnings on 25 Feb 2026, higher-than-average volume **8,254.00**, and market attention on short-interest in related US listings. Traders were pricing event risk and guidance updates.

How does Meyka AI rate 4LL.F stock and what does it mean?

Meyka AI scores 4LL.F **69.86/100 (Grade B, HOLD)**. The grade blends benchmark, sector, growth, metrics and analyst signals. It’s informational only and not investment advice.

What is Meyka AI's price forecast for 4LL.F stock?

Meyka AI's forecast model projects a 12-month target of **€6.20**, implying about **49.40%** upside from **€4.15**. Forecasts are model-based projections and not guarantees.

What key risks should investors watch for 4LL.F stock?

Main risks include continued negative EPS, weak interest coverage, and revenue or membership shortfalls. Earnings guidance and US-listed flows that affect liquidity on XETRA are critical near-term risks.

DE Stocks

After Hours: Teladoc Health (4LL.F XETRA) €4.15 +5.83% on 23 Feb 2026: watch upcoming earnings

ByHuzaifa Zahoor February 23, 2026

4LL.F stock jumped after hours to €4.15, up 5.83%, on 23 Feb 2026 as traders reacted ahead of Teladoc Health’s earnings event. Volume printed at 8,254.00 versus an average of 1,369.00, signaling heavier activity in XETRA trade. The move follows sustained weakness year-to-date and a low near €3.71 this year, prompting short-term traders to reprice risk ahead of the company’s results and management commentary.